









|
|
The Colon Cancer Information Center provides in-depth information on colon cancer, colorectal cancer and treatment with Camptosar® (irinotecan, also known as CPT-11). The colon cancer information is intended for use by both oncology professionals and patients in the United States.
|
|  |
|
New Data: First Line Combination Therapy with Camptosar
- Colon Cancer: Information for Health Care Professionals from the National Cancer Institute (PDQ Database)
- Ten Best Readings in Colorectal Cancer — Richard C. Carl, MD — Cancer Control Journal, H. Lee Moffitt Cancer Center
- Colorectal Cancer — Editorial — Richard C. Carl, MD — Cancer Control Journal, H. Lee Moffitt Cancer Center
- Colorectal Cancer 2004 — Current Treatments and Future Directions
- Moving Ahead — Challenges With Combination Therapies for Colorectal Cancer
- Molecular Basis of Colon Cancer — Bert Vogelstein, MD, Johns Hopkins, University School of Medicine
- Strategies to Lessen the Current Failure Rate in Colorectal Cancer — Society of Surgical Oncology
- Diagnostic and Therapeutic Procedures — American Society of Gastrointestinal Endoscopy
- Screening for Colorectal Cancer — Mindy Schwartz, MD, University of Chicago
- Screening for Colorectal Cancer — Bernard Levin, MD — Cancer Control Journal, H. Lee Moffitt Cancer Center
- Heriditary Colon Cancer Newsletter — M.D. Anderson Cancer Center
- CancerLit Search — Therapy of Colorectal Cancer
- CancerLit Search — Screening and Prevention of Digestive Cancers
- Clinical Trials — National Cancer Institute
Product Information
Patient Information
Cancer Library Index
Top
©Copyright 1995-2012 Ultitech, Inc. All Rights Reserved.
|